ANXA2 and metabolic dysfunction-associated steatotic liver disease: Moreover, ANXA2 manifested in a cluster positively correlated with the stage of liver fibrosis (F0-F4) in our human dataset, indicating its importance in the progression of NAFLD, especially during fibrosis (Supplementary Figure S4B).